Herbal medicines for liver diseases - PubMed (original) (raw)
Review
Herbal medicines for liver diseases
Radha K Dhiman et al. Dig Dis Sci. 2005 Oct.
Abstract
Herbal medicines have been used in the treatment of liver diseases for a long time. A number of herbal preparations are available in the market. This article reviews four commonly used herbal preparations: (1) Phyllanthus, (2) Silybum marianum (milk thistle), (3) glycyrrhizin (licorice root extract), and (4) Liv 52 (mixture of herbs). Phyllanthus has a positive effect on clearance of HBV markers and there are no major adverse effects; there are no data from randomized controlled trials on clinically relevant outcomes, such as progression of chronic hepatitis to cirrhosis and/or liver cancer, and on survival. Silymarin does not reduce mortality and does not improve biochemistry and histology among patients with chronic liver disease; however, it appears to be safe and well tolerated. Stronger neominophagen C (SNMC) is a Japanese preparation that contains 0.2% glycyrrhizin, 0.1% cysteine, and 2% glyceine. SNMC does not have antiviral properties; it primarily acts as an anti-inflammatory or cytoprotective drug. It improves mortality in patients with subacute liver failure and improves liver functions in patients with subacute hepatic failure, chronic hepatitis, and cirrhosis with activity. SNMC does not reduce mortality among patients with cirrhosis with activity. SNMC may prevent the development of hepatocellular carcinoma in patients with chronic hepatitis C, however, prospective data are lacking. Liv 52, an Ayurvedic hepatoprotective agent, is not useful in the management of alcohol-induced liver disease. Standardization of herbal medicines has been a problem and prospective, randomized, placebo-controlled clinical trials are lacking to support their efficacy. The methodological qualities of clinical trials of treatment with herbal preparations are poor. The efficacy of these herbal preparations need to be evaluated in rigorously designed, larger randomized, double-blind, placebo-controlled multicenter trials.
Similar articles
- Use of herbal supplements for chronic liver disease.
Levy C, Seeff LD, Lindor KD. Levy C, et al. Clin Gastroenterol Hepatol. 2004 Nov;2(11):947-56. doi: 10.1016/s1542-3565(04)00455-0. Clin Gastroenterol Hepatol. 2004. PMID: 15551246 Review. - Beneficial drugs for liver diseases.
Muriel P, Rivera-Espinoza Y. Muriel P, et al. J Appl Toxicol. 2008 Mar;28(2):93-103. doi: 10.1002/jat.1310. J Appl Toxicol. 2008. PMID: 17966118 Review. - Does herbal medicine reduce the risk of hepatocellular carcinoma?
Rino Y, Yukawa N, Yamamoto N. Rino Y, et al. World J Gastroenterol. 2015 Oct 7;21(37):10598-603. doi: 10.3748/wjg.v21.i37.10598. World J Gastroenterol. 2015. PMID: 26457019 Free PMC article. Review. - Herbal medicine in the treatment of liver diseases.
Stickel F, Schuppan D. Stickel F, et al. Dig Liver Dis. 2007 Apr;39(4):293-304. doi: 10.1016/j.dld.2006.11.004. Epub 2007 Feb 28. Dig Liver Dis. 2007. PMID: 17331820 Review. - Review of clinical trials evaluating safety and efficacy of milk thistle (Silybum marianum [L.] Gaertn.).
Tamayo C, Diamond S. Tamayo C, et al. Integr Cancer Ther. 2007 Jun;6(2):146-57. doi: 10.1177/1534735407301942. Integr Cancer Ther. 2007. PMID: 17548793 Review.
Cited by
- Milk thistle protects against non-alcoholic fatty liver disease induced by dietary thermally oxidized tallow.
Neelab, Zeb A, Jamil M. Neelab, et al. Heliyon. 2024 May 17;10(10):e31445. doi: 10.1016/j.heliyon.2024.e31445. eCollection 2024 May 30. Heliyon. 2024. PMID: 38818175 Free PMC article. - Computational identification of potential bioactive compounds from Triphala against alcoholic liver injury by targeting alcohol dehydrogenase.
Banjan B, Raju R, Keshava Prasad TS, Abhinand CS. Banjan B, et al. Mol Divers. 2024 May 14. doi: 10.1007/s11030-024-10879-9. Online ahead of print. Mol Divers. 2024. PMID: 38743308 - The antiviral potential of Phyllanthus species: a systematic review.
Upadhyay R, Tiwari KN. Upadhyay R, et al. Arch Virol. 2023 Jun 13;168(7):177. doi: 10.1007/s00705-023-05802-w. Arch Virol. 2023. PMID: 37310509 Review. - Livogrit, a herbal formulation of Boerhavia diffusa, Phyllanthus niruri and Solanum nigrum reverses the thioacetamide induced hepatocellular toxicity in zebrafish model.
Balkrishna A, Lochab S, Varshney A. Balkrishna A, et al. Toxicol Rep. 2022 Apr 29;9:1056-1064. doi: 10.1016/j.toxrep.2022.03.053. eCollection 2022. Toxicol Rep. 2022. PMID: 35571233 Free PMC article.
References
- J Gastroenterol Hepatol. 1997 Mar;12(3):243-8 - PubMed
- Phytochemistry. 1995 Jan;38(2):307-14 - PubMed
- Indian J Exp Biol. 1999 Aug;37(8):762-6 - PubMed
- Cancer. 1997 Apr 15;79(8):1494-500 - PubMed
- Indian J Exp Biol. 1994 Oct;32(10 ):694-7 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical